26614 Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices

guidance to this policy is contained in

the Federal Register, Vol. 60, No. 179,

pages 47947–47951, and dated Friday,

September 15, 1995.

Paperwork Reduction Act

Projects that involve the collection of

information from 10 or more individuals

and funded by the cooperative

agreement will be subject to review by

the Office of Management and Budget

(OMB) under the Paperwork Reduction

Act.

Application Submission and Deadline

The original and two copies of the

application PHS Form 5161–1 (Revised

7/92, OMB Control number 0937–0189)

must be submitted to Joanne Wojcik,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 300,

Mailstop E–13, Atlanta, GA 30305, on or

before July 14, 1998.

1. Deadline: Applications shall be

considered as meeting the deadline if

they are either:

a. Received on or before the deadline

date; or

b. Sent on or before the deadline date

and received in time for submission to

the independent review committee. For

proof of timely mailing, applicant must

request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or the U.S. Postal Service. Private

metered postmarks will not be

acceptable as proof of timely mailing.

2. Late Applications: Applications

that do not meet the criteria in 1.a. or

1.b. above are considered late

applications. Late applications will not

be considered in the current

competition and will be returned to the

applicant.

Where To Obtain Additional

Information

The program announcement and

application forms may be downloaded

from internet: www.cdc.gov (look under

funding). You may also receive a

complete application kit by calling 1–

888-GRANTS4. You will be asked to

identify the program announcement

number and provide your name and

mailing address. A complete

announcement kit will be mailed to you.

If you have questions after reviewing

the forms, for business management

technical assistance contact Joanne

Wojcik, Grants Management Specialist,

Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Mailstop E–13, Atlanta, GA 30305,

Internet: jcw6@cdc.gov, telephone (404)

842–6535.

Programmatic assistance may be

obtained from Mark Jackson, R.S.,

National Center for Injury Prevention

and Control, Centers for Disease Control

and Prevention (CDC), 4770 Buford

Highway, NE., Mailstop K–63, Atlanta,

GA 30341–3724, telephone (770) 488–

4652.

Please refer to Announcement 98054

when requesting information and

submitting an application.

The potential applicant may obtain a

copy of ‘‘Healthy People 2000’’ (Full

Report, Stock No. 017–001–00474–0) or

‘‘Healthy People 2000’’ (Summary

Report, Stock No. 017–001–00473–1)

referenced in the INTRODUCTION

through the Superintendent of

Documents, Government Printing

Office, Washington, DC 20402–9325,

telephone (202) 512–1800.

A copy of American Society for

Testing and Materials (ASTM) Number

1292 may be obtained from ASTM,

Customer Services, 1916 Race Street,

Philadelphia, PA 19103–1187,

telephone (215) 299–5585.

Dated: May 7, 1998.

Joseph R. Carter,

Acting Associate Director for Management

and Operations Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–12644 Filed 5–12–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 98046]

National Comprehensive Cancer

Control Program; Notice of Availability

of Fiscal Year 1998 Funds

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of funds in fiscal year (FY)

1998 for cooperative agreements to

implement comprehensive cancer

control plans.

CDC is committed to achieving the

health promotion and disease

prevention objectives of ‘‘Healthy

People 2000,’’ a national activity to

reduce morbidity and mortality and to

improve the quality of life. This

announcement is related to the priority

area of Cancer. (To order a copy of

‘‘Healthy People 2000,’’ see the section

‘‘Where To Obtain Additional

Information.’’)

Authority

This program is authorized by

Sections 317 and 1507 [42 U.S.C. 247b]

and [42 U.S.C. 300n–3] of the Public

Health Service Act, as amended.

Smoke-Free Workplace

CDC strongly encourages all grant

recipients to provide a smoke-free

workplace and to promote the nonuse of

all tobacco products, and Public Law

103–227, the Pro-Children Act of 1994,

prohibits smoking in certain facilities

that receive federal funds in which

education, library, day care, health care,

and early childhood development

services are provided to children.

Eligible Applicants

Assistance will be provided only to

the official public health agencies of

States or their bona fide agents,

including the District of Columbia, the

Commonwealth of Puerto Rico, the

Virgin Islands, the Commonwealth of

the Northern Mariana Islands, American

Samoa, Guam, federally recognized

Indian tribal governments, the

Federated States of Micronesia, the

Republic of the Marshall Islands, and

the Republic of the Palau. In

consultation with States, assistance may

be provided to political subdivisions of

States.

Applicants must complete the

Eligibility Assurance Form included in

the application packet and must attach

a reproducible copy of the State/Tribe/

Territory’s comprehensive Cancer

Control Plan to that form. Only one

eligible application from a State/Tribe/

Territory will be funded. Applicants

from each State/Tribe/Territory are

encouraged to coordinate and combine

their efforts prior to submitting the

application for their State/Tribe/

Territory.

Availability of Funds

Approximately $1.5 million is

available in FY 1998 to fund

approximately 5 awards. It is expected

that the average award will be $300,000

ranging from $250,000 to $350,000. It is

expected that these awards will begin

on or about September 30, 1998, and

will be made for 12-month budget

periods within a project period of up to

4 years. Funding estimates may vary

and are subject to change.

Continuation awards within the

project period will be made on the basis

of satisfactory progress as evidenced by

required reports and the availability of

funds.

Use of Funds

These funds are intended for

comprehensive cancer control and
Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices 26615

should not be used to directly support

other existing programs such as breast

and cervical cancer programs, cancer

registry programs, laboratory or clinical

services, or tobacco control programs.

These funds should be used to assist

with the coordination of these and other

categorical programs into

comprehensive cancer control activities.

Funds awarded under this program

announcement may not be used to

supplant existing program efforts.

Comprehensive cancer control

activities should adhere to current

accepted public health

recommendations by the U.S.

Preventive Services Task Force, or

current Division of Cancer Prevention

and Control (DCPC) guidance (See

Section on Where To Obtain Additional

Information).

In the event that additional federal

categorical funding becomes available

under this announcement, Grantees

must coordinate and integrate newly

funded activities into the existing

National Comprehensive Cancer Control

Program.

Restrictions on Lobbying

Applicants should be aware of

restrictions on the use of HHS funds for

lobbying of Federal or State legislative

bodies. Under the provisions of 31

U.S.C. Section 1352 (which has been in

effect since December 23, 1989),

recipients (and their subtier contractors)

are prohibited from using appropriated

Federal funds (other than profits from a

Federal contract) for lobbying congress

or any Federal agency in connection

with the award of a particular contract,

grant, cooperative agreement, or loan.

This includes grants/cooperative

agreements that, in whole or in part,

involve conferences for which Federal

funds cannot be used directly or

indirectly to encourage participants to

lobby or to instruct participants on how

to lobby.

In addition, the FY 1998 Department

of Labor, Health and Human Services,

and Education, and Related Agencies

Appropriations Act (Public Law 105–78)

states in Section 503 (a) and (b) that no

part of any appropriation contained in

this Act shall be used, other than for

normal and recognized executivelegislative relationships, for publicity or

propaganda purposes, for the

preparation, distribution, or use of any

kit, pamphlet, booklet, publication,

radio, television, or video presentation

designed to support or defeat legislation

pending before the Congress or any

State Legislature, except in presentation

to the Congress or any State legislature

itself. No part of any appropriation

contained in this Act shall be used to

pay the salary or expenses of any grant

or contract recipient, or agent acting for

such recipient, related to any activity

designed to influence legislation or

appropriations pending before the

Congress or any State legislature.

Background

In the United States, cancer is the

second leading cause of death, exceeded

only by heart disease. Among adults

younger than 65 years, cancer is the

leading cause of death and is rapidly

overtaking heart disease as the primary

cause of death among older Americans

(Kennedy 1994). One of every four

deaths in the United States is from

cancer with approximately 564,800

people expected to die of cancer this

year (American Cancer Society 1998).

The overall cancer death rate has been

steadily rising in the United States

during the last 50 years. The ageadjusted death rate in 1950 was 127.7

per 100,000 population (National Center

for Health Statistics 1968); it rose to

129.9 per 100,000 in 1995 (National

Center for Health Statistics 1997).

While cancer currently is a major

cause of morbidity and mortality in the

United States, a large proportion of

cancer could be controlled through

prevention, early detection, and

treatment. In recent years, DCPC has

worked with state and local health

agencies to increase the number and

quality of cancer-related programs that

are available to the U.S. population.

New organizational structures,

increased professional expertise,

improved understanding of the

challenges of delivering communitybased health education and health

promotion and an increased ability to

demonstrate program accountability to

program funders have reinforced the

public health infrastructure available for

cancer prevention and control at the

national, State and community levels. In

addition, in 1997, an American Cancer

Society-appointed Blue Ribbon

Advisory Group on Community Cancer

Control recommended that prevention

be a primary goal and focus. (American

Cancer Society 1997).

The majority of the programs

developed by CDC are categorical in

nature, i.e., built around specific cancer

sites or risk factors. For example, CDC

has developed important initiatives and

programs to address breast and cervical

cancer, skin cancer, colorectal cancer,

prostate cancer, oral cancer, nutrition

and physical activity, and tobacco

control; these categorical programs

indicate impressive accomplishments in

their areas. However, coordination and

collaboration among these programs are

uncommon, often leading to duplication

of effort and missed opportunities for

cancer prevention and control at the

community level.

In 1994, DCPC initiated discussions

related to the coordination and

integration of cancer prevention and

control programs across categorical

boundaries. DCPC sponsored a number

of activities to explore options for

comprehensive cancer control. One of

the key tasks was to develop a working

definition of comprehensive cancer

control. The following definition was

determined to be encompassing and

appropriate for future planning and

implementation activities:

Comprehensive cancer control—an

integrated and coordinated approach to

reduce the incidence, morbidity and

mortality [of cancer] through

prevention, early detection, treatment,

rehabilitation, and palliation.

Purpose

The purpose of this program is to

support States/Tribes/Territories in the

implementation of up-to-date State/

Tribe/Territory wide comprehensive

cancer control plans. (See Glossary for

definitions of comprehensive cancer

control plan and comprehensive cancer

control program.)

Program Requirements

Recipients of this funding should

adhere to current accepted public health

recommendations based on the U.S.

Preventive Services Task Force, or

current DCPC guidance (See Section on

Where To Obtain Additional

Information).

In conducting activities to achieve the

purpose of this program, the recipient of

this cooperative agreement will be

responsible for the activities under A.

(Recipient Activities), and CDC will be

responsible for conducting activities

under B. (CDC Activities).

A. Recipient Activities

1. Identify and hire necessary key staff

to implement the comprehensive cancer

control plan.

2. Maintain or enhance a broad-based

state/tribe/territorywide cancer control

coalition that includes representation

from throughout the state/tribe/territory

health department, as well as key

private, professional, voluntary, and

nonprofit cancer control organizations,

policymakers, consumers (including

cancer survivors), payors, media, State

and federal agencies, cancer registries,

research and academic institutions,

schools, etc.

3. Implement priorities as established

by the State/Tribe/Territory’s

comprehensive cancer control plan,

which provides a framework for
26616 Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices

planning and action to reduce the

burden of cancer in the State/Tribe/

Territory. Implementation should be

guided by goals and objectives

documented in the implementation plan

included in this application.

4. Promote collaboration and

coordination among existing State/

Tribe/Territory-based surveillance

systems (e.g., the statewide Central

Cancer Registry, Surveillance,

Epidemiology, and End Results, (SEER),

vital statistics, and other databases,

including Behavioral Risk Factor

Surveillance System (BRFSS), for use in

monitoring changes in cancer disease

burden and programmatic impact of the

comprehensive cancer control efforts.

Data should be used for program

modifications and improvements,

evaluation, and updating the

comprehensive cancer control plan, as

appropriate.

5. Evaluate progress and impact of the

program based on a systematic

evaluation plan. In addition to

evaluating progress in meeting goals,

process and impact objectives as stated

in the implementation plan, the

programs should develop performance

indicators to use as benchmarks for

improvement and to determine the

success of the overall comprehensive

cancer control effort.

6. Promote the development and

dissemination of information and

education programs that will contribute

to comprehensive cancer control; and

participate in CDC-developed national

cancer prevention, early detection, and

control campaigns. Programs should use

existing education resources as well as

develop materials and activities that

address specific needs of their

populations, as necessary and

appropriate. School health education

and policies should be considered as

part of these strategies. In addition to

addressing educational needs of the

targeted populations, programs should

also consider activities that attempt to

make individual, policy, organizational

or environmental interventions and

changes that can encourage primary

prevention at all levels, e.g.,

organizational changes that can

reinforce and support individual

behavior changes.

7. Participate in CDC-sponsored

trainings, meetings, site visits, and

conferences.

B. CDC Activities

1. Convene meetings for informationsharing or training among recipients of

cooperative agreements.

2. Facilitate the exchange of

information and collaboration among

recipients.

3. Disseminate to recipients relevant

state-of-the-art research findings and

public health recommendations related

to comprehensive cancer control.

4. Provide ongoing guidance,

consultation, and technical assistance in

conducting Recipient Activities.

5. Conduct site visits to assess

program progress, and mutually resolve

problems, as needed, and coordinate

reverse site visits to CDC in Atlanta,

Georgia.

6. Identify and develop national

cancer prevention and control

campaigns and materials that can be

integrated into comprehensive cancer

control programs; facilitate coordination

between programs and CDC on national

campaigns.

Technical Reporting Requirements

An original and two copies of an

annual progress report must be

submitted 30 days after the end of each

budget period. These progress reports

must include: (1) a comparison of actual

accomplishments to the goals and

objectives established for the period; (2)

activities and other issues to be

addressed during the subsequent

reporting period. The final performance

report is required no later than 90 days

after the end of the project period.

Annual financial status report (FSR)

must be submitted no later than 90 days

after the end of each budget period. The

final financial status and progress

reports are required no later than 90

days after the end of the project period.

All reports are submitted to Grants

Management Branch, CDC.

Application Content

All applicants must develop their

applications in accordance with

information contained in this program

announcement and the instructions

below. Applications should not exceed

30 double-spaced pages (no smaller than

10 point type) including budget and

justification. Applicants should also

submit appendices (including CVs, job

descriptions, organizational chart, and

any other supporting documentation),

which should not exceed an additional

20 pages. All materials must be

provided in an unbound, one-sided, 81⁄2

x 11′′ print format, suitable for

photocopying (i.e., no audiovisual

materials, posters, tapes, etc.). A

reproducible copy of the State/Tribe/

Territory’s comprehensive cancer

control plan (attached to the Eligibility

Assurance Form), and the letters of

support should be included in separate

tabbed sections of the application. (The

comprehensive cancer control plan and

letters of support are not included in the

page limit for the application or

appendices.)

I. Executive Summary

The applicant should provide a clear,

concise one to two page written

summary to include:

A. The need for implementing the

comprehensive cancer control plan.

B. The major proposed objectives and

activities for implementation of the

comprehensive cancer control plan.

C. The requested amount of federal

funding.

D. Applicant’s capability to

implement the comprehensive cancer

control plan.

II. Background and Need

The applicant should describe:

A. The cancer disease burden for their

State/Tribe/Territory:

1. The most recently available State/

Tribe/Territory, age-adjusted, overall

cancer incidence and mortality rates by

age, gender, and racial and ethnic

groups. Please cite the source for and

time period covered by these data.

2. The estimated State/Tribe/Territory

cancer incidence and mortality rates for

1998.

(Please refer to the section on ‘‘Where To

Obtain Additional Information’’ for possible

data sources.)

B. Relevant experiences in the

development and implementation of

cancer prevention and control programs.

C. Relevant experiences in

coordination and collaboration between

and among existing programs.

D. Existing initiatives, capacity, and

infrastructure (e.g., coalition and

partnerships; surveillance activities and

systems; evaluation activities;

information, media and health

communications, education and

outreach strategies) on which a

coordinated comprehensive cancer

control program will be established.

E. Description of the need for

comprehensive cancer control funding

to enhance existing efforts.

III. Collaborative Partnership and

Community Involvement

The applicant should include:

A. A description of proposed linkages

to coordinate within the State/Tribe/

Territory health department (e.g., across

risk factors, categorically funded

programs, disciplines), with other key

private, professional, voluntary, and

non-profit cancer control organizations,

policymakers, consumers (including

cancer survivors), payors, federal, State

and local agencies, research and

academic institutions, schools, and

other groups, agencies, and businesses

in the community that provide health

care and related human services.
Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices 26617

B. A description of the proposed

broad-based State/Tribe/Territory wide

coalition that will advise and support

the program, including the

identification of current members or

proposed representatives, their charge,

and proposed roles and responsibilities.

Taking a broad cancer prevention and

control perspective, the State/Tribe/

Territory should consider including a

wide range of representatives from risk

factor and other public health programs

that address cancer-related issues such

as, nutrition, environmental, oral health,

and school health activities. Specific

subcommittees and the rationale for

these subcommittees of the coalition

should be described.

C. Letters of support (in a separate

tabbed section of the application) that

indicate the nature and extent of

existing or planned collaborative

support.

IV. Cancer Control Plan

The applicant should:

A. Submit a copy of the (a) current

existing state/tribe/territory wide

comprehensive cancer control plan, or

(b) a current detailed final draft plan.

Attach a reproducible, one-sided, 81⁄2 x

11′′ unbound copy of the plan, to the

completed Eligibility Assurance Form.

A comprehensive cancer control plan

should include:

1. An assessment of cancer burden in

the State/Tribe/Territory using

population-based data.

2. Short-term and long-term goals and

objectives to address cancer control

issues within the State/Tribe/Territory

based on identified needs.

3. Proposed strategies to meet the

objectives.

4. An assessment of existing and

needed resources to implement the

comprehensive cancer control priorities.

5. The full range of cancer prevention

and control activities, including primary

prevention, early detection, diagnosis,

treatment, rehabilitation and palliation.

B. Describe the process by which the

plan was developed. (If the plan is in

draft, describe the process for assuring

readiness for implementation by

September 30, 1998.) Include a

description of the participating

agencies’ and organizations’

involvement in the development of the

plan. Clearly describe a mechanism to

review, evaluate, and update the plan to

meet evolving needs.

C. Describe who will be responsible

for maintaining the comprehensive

cancer control plan and assuring that

the coalition is involved throughout the

process, and that comprehensive cancer

control efforts proceed according to the

State/Tribe/Territory’s plan.

V. Implementation of the

Comprehensive Cancer Control Plan

The successful coordination and

integration of cancer activities, based on

the comprehensive cancer control plan,

requires that priorities be determined

based on a clear data-driven rationale

and justification.

The applicant should include an

implementation plan that:

A. Describes the process for

determining priorities to be addressed

in implementing the comprehensive

cancer control plan, the process for

assuring that these decisions are databased and grounded in sound science,

and the role of the coalition and/or

collaborators in the priority-setting

process.

B. Includes specific, measurable,

attainable, realistic, and time-framed

process and outcome objectives

designed to achieve goals identified in

the comprehensive cancer control plan.

The implementation plan for this RFA

need not address each goal and

objective outlined in the comprehensive

cancer control plan; the applicant

should make clear how goals and

objectives resulting from the prioritysetting process relate to the

comprehensive cancer control plan.

C. Provides a description of the

process for implementing goals and

objectives for the identified priorities of

the comprehensive cancer control plan.

This should include discrete

timeframes; responsible agencies,

organizations, or organizational units;

and activities proposed to meet the

objectives within the comprehensive

cancer control plan. It should also

include a description of how the

proposed activities will facilitate

coordination and cooperation among

existing categorical program efforts. The

applicant should include goals for all

four years, and specific objectives for

Year 01.

D. Describes how surveillance data

will be integrated into program

activities and used to assess program

progress, and inform program decision

making.

Description should include evidence

that existing surveillance systems

enable programs to do the following:

1. Collect population-based

information on the demographics,

incidence, staging of cancer at

diagnosis, morbidity and mortality from

cancer. Mechanisms should be in place

to ensure timeliness, quality, and

completeness of data.

2. Identify segments of the population

who are at higher risk for incidence,

morbidity, and mortality.

3. Identify factors contributing to the

disease burden, such as behavioral risk

factors and limited or inequitable access

to services.

4. When appropriate, monitor the

number and characteristics of people

served by relevant programs.

5. When appropriate, develop

linkages between the above-mentioned

data bases and routinely monitor to

determine the effectiveness of

interventions.

E. Includes the current or proposed

plan for evaluating (1) the program’s

progress in meeting specific objectives

outlined in the implementation plan,

and (2) overall success of the

comprehensive cancer control effort,

based on indicators established by the

applicant. Describe the types of

indicators to be used to assess outcomes

such as coordination, integration and

collaboration that have occurred as a

result of this funding. Such indicators

might assess organizational or

institutional changes, reduced

duplication of effort, environmental and

policy changes. Baseline measures

should be identified and assessed, to

allow for comparisons after

implementation has begun. For each

type of evaluation, specify the kind of

data/indicator that will be used, how

the data will be obtained, how

information will be used to improve the

overall program, as well as individual

program components, who is

responsible for each evaluation task,

and a time line for accomplishing each

evaluation task.

F. Describes proposed information

and education efforts. Identify the

mechanisms through which

information, material, and successful

strategies will be consistently and

systematically shared and disseminated

at the State/Tribe/Territory and local

levels, as well as with other cooperative

agreement recipients. Include in this

description a discussion of plans for

collaborating with CDC on national

campaigns or educational efforts.

G. Describes mechanism for assuring

that the core components of a

comprehensive cancer control program

including primary prevention/risk factor

reduction; education, outreach, health

communications; screening, diagnostic,

and treatment services; surveillance;

and evaluation are consistent with

accepted science and prevailing

standards of public health practice. The

primary prevention components should

address risk factors that will have the

greatest impact on reducing the overall

disease burden of cancer and are not

limited to prevention activities of the

specific cancers addressed in the State/

Tribe/Territory’s comprehensive cancer

control program.
26618 Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices

H. Describes existing programs

funded by other sources that will be

coordinated with the comprehensive

cancer control effort.

VI. Management and Organization

The applicant should:

A. Submit a management plan that

includes a description of the proposed

management structure that addresses

the use of qualified and diverse

technical, program, and administrative

staff (including in-kind staff),

organizational relationships including

lines of authority, internal and external

communication systems, and a system

for sound fiscal management. Minimal

staffing should include a full-time

program coordinator. The management

structure description should include

discussion of the integration and

coordination of risk factor and cancerrelated programs and activities. It is

important that the management plan

address how coordination and

cooperation among existing categorical

program efforts will be facilitated, while

allowing each program to maintain

individual integrity and identity.

B. Provide (in the appendices) a copy

of the organizational chart indicating

the placement of the proposed program

in the department or agency. The chart

should clearly demonstrate internal

linkages necessary for comprehensive

cancer control planning,

implementation and evaluation.

C. Provide (in the appendices) CVs

and job descriptions of key staff to be

partially or fully funded through this

RFA, as well as any staff to be providing

in-kind support. Applicant should

clearly indicate who is responsible for

overall direction of the program.

VII. Budget With Justification

The applicant should provide a

detailed budget request and complete

line item justification of all proposed

operating expenses consistent with the

Recipient Activities. If in-kind

contributions are being provided by the

applicant, these should be documented.

The annual budget should include

funds for two staff members to make

two two-day trips to Atlanta.

Non-Competing Continuation

Application Content

In compliance with 45 C.F.R.

92.10(b)(4), as applicable, noncompeting

continuation applications submitted

within the project period need only

include:

A. A progress report describing the

accomplishments made from award date

to the date of the continuation

application. These progress reports must

include: (1) a comparison of actual

accomplishments with the goals and

objectives established for the period,

and

(2) other activities and issues to be

addressed during the subsequent

reporting period.

B. Any new or significantly revised

items or information (objectives, scope

of activities, operational methods,

evaluation, etc.) not included in the

Year 01 application.

C. An annual budget and justification.

Existing budget items that are

unchanged from the previous budget

period do not need rejustification.

Simply list the items in the budget and

indicate that they are continuation

items. Supporting justification should

be provided where appropriate.

Evaluation Criteria (Total 100 Points)

Objective Review panels evaluate the

scientific and technical merit of

applications and their responsiveness to

the information requested in the

Application Content section above.

Applications will be reviewed and

evaluated according to the following

criteria:

I. Background and Need (10 points)

The extent of need based on disease

burden by age, gender, and racial and

ethnic groups, mortality rates,

incidence, cancer program experience,

existing capacity and infrastructure, and

funding need.

II. Collaborative Partnership and

Community Involvement (15 points)

The comprehensiveness and

appropriateness of:

A. Existing or proposed linkages

within and outside the State/Tribe/

Territory health department to

coordinate diverse cancer control, risk

factor and other primary prevention

programs and activities among various

agencies, organizations, professional

groups, and individuals.

B. The current or proposed broadbased State/Tribe/Territory wide

coalition to advise and support the

program, including defined roles,

responsibilities, and specified

subcommittees.

C. Letters of support that indicate the

nature and extent of existing or planned

collaborative support.

III. Cancer Control Plan (15 points)

The quality of the comprehensive

cancer control plan in terms of:

A. An integrated and coordinated

State/Tribe/Territory wide approach to

prevention, early detection, treatment,

rehabilitation, and palliation of cancer;

assessment of the State/Tribe/Territory’s

cancer burden; short-term and long-term

goals, objectives, and strategies to

address cancer control issues;

assessment of existing and needed

resources to develop the comprehensive

cancer control program; the full range of

cancer prevention and control activities,

including primary prevention, early

detection, diagnosis, treatment,

rehabilitation and palliation.

B. The extent to which a broad range

of partners and stakeholders are

included throughout the process to

develop, implement, review, and update

the plan; mechanisms to review,

evaluate and update the plan to meet

evolving needs, and personnel who will

be responsible for maintaining the plan,

assuring that it is current and regularly

reviewed and updated are clearly

identified.

IV. Implementation of the

Comprehensive Cancer Control Plan (35

points)

The extent to which the applicant’s

implementation plan describes:

A. Process, justification, and rationale

for priorities established for

implementation.

B. Specific, measurable, realistic,

time-framed objectives based on the

comprehensive cancer control plan.

C. The process for implementing

priorities identified in the plan, to

include discrete time frames,

responsible agencies and organizations,

linkages of activities to objectives, and

how the proposed activities will

facilitate coordination and collaboration

among existing categorical program

efforts.

D. How surveillance data will be

integrated into program activities and

used to assess program progress and

assist program decision making; the

surveillance systems and collection of

relevant and appropriate populationbased information on the demographics,

behavioral, disease burden and

incidence, etc.; and any linkages

between databases and routine

monitoring to determine effectiveness of

interventions.

E. Plans for evaluating the program’s

progress in meeting specific objectives

outlined in the implementation plan,

and overall success of the

comprehensive cancer control effort.

F. Proposed information and

education efforts, including

collaborating with CDC on national

campaigns.

G. Methods for assuring that: the core

components of a comprehensive cancer

control program including primary

prevention/risk factor reduction;

education, outreach, and health

communications; screening, diagnostic,

and treatment services; surveillance;
Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices 26619

and evaluation are consistent with

accepted science and prevailing public

health practice; the primary prevention

components address risk factors that

will have the greatest impact on

reducing the overall disease burden of

cancer and are not limited to prevention

activities of the specific cancers

addressed in the State/Tribe/Territory’s

comprehensive cancer control program.

H. Description of other existing

programs funded by other sources that

will be coordinated with the

comprehensive cancer control effort.

V. Management and Organization (25

points)

A. The feasibility and clarity of the

proposed management plan that

addresses the use of qualified and

diverse technical, program, and

administrative staff, organizational

relationships including lines of

authority, internal and external

communication systems, cooperation

and coordination among categorical

cancer-related programs, and a system

for sound fiscal management.

B. The appropriateness of the

organizational structure and the existing

and proposed internal and external

linkages.

C. The quality and appropriateness of

CVs and job descriptions of current and

proposed key staff, to include who is

responsible for overall direction of the

program.

VI. Budget With Justification (Not

Weighted)

The extent to which the proposed

budget is adequately justified,

reasonable, and consistent with this

program announcement.

Executive Order 12372 Review

Applications are subject to

Intergovernmental Review of Federal

Programs as governed by Executive

Order 12372. This order sets up a

system for State/Territory/Tribe and

local review of proposed federal

assistance applications. Applicants

should contact their State Single Point

of Contact (SPOC) as early as possible to

alert them to expected announcements

of cooperative agreement funds and

receive any necessary instructions on

the State process. For proposed projects

serving more than one State, the

applicant is advised to contact the SPOC

of each State. A current list of SPOCs is

included in the application kit. Indian

territories are strongly encouraged to

request tribal government review of the

proposed application. If tribal

governments have any tribal process

recommendations or if SPOCs have any

State process recommendations on

applications submitted to CDC, they

should send them to Sharron P. Orum,

Grants Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 305,

Mailstop E–18, Atlanta, GA 30305, no

later than 60 days after the application

deadline date. The Program

Announcement Number and Program

Title should be referenced on the

document. The granting agency does not

guarantee to accommodate or explain

the State or tribal process

recommendations it receives after that

date.

Public Health System Reporting

Requirements

This program is not subject to the

Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance Number is 93.919.

Other Requirements

Paperwork Reduction Act

Projects that involve the collection of

information from 10 individuals or more

and funded by cooperative agreement

will be subject to review by the Office

of Management and Budget (OMB)

under the Paperwork Reduction Act.

Application Submission and Deadline

The original and two copies of the

completed application Form CDC

0.1246(E) (OMB Number 0348–0043)

must be submitted to Sharron P. Orum,

Grants Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 314,

Mailstop E–18, Atlanta, GA 30305 on or

before July 1, 1998.

1. Applications shall be considered as

meeting the deadline if they are either:

a. Received on or before the stated

deadline date; or

b. Sent on or before the deadline date

and received in time for submission to

the objective review group. (Applicants

must request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or the U.S. Postal Service. Private

metered postmarks shall not be accepted

as proof of timely mailing.)

2. Late Applications. Applications

that do not meet the criteria in 1.a. or

1.b., above, are considered late

applications. Late applications will not

be considered in the current

competition and will be returned to the

applicant.

3. Acceptable Materials. Applicants

must send all materials in an unbound,

one-sided 81⁄2 x 11′′ printed format,

suitable for photocopying. All other

application materials will not be

reviewed.

4. Only one eligible application from

a State/Tribe/Territory will be funded.

Applicants from each State/Tribe/

Territory are encouraged to coordinate

and combine their efforts prior to

submitting the application for their

State/Tribe/Territory.

Where To Obtain Additional

Information

Complete information on application

procedures is contained in the

application package. Business

management technical assistance may

be obtained from Gladys T. Gissentanna,

Grants Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE., Room 314,

Mailstop E–18, Atlanta, GA 30305,

telephone (404) 842–6801; by fax (404)

842–6513; by Internet or CDC WONDER

electronic mail at gcg4@cdc.gov.

Programmatic technical assistance

may be obtained from Jeannette May,

MPH, or Diane Narkunas, MPH,

Program Services Branch, Division of

Cancer Prevention and Control, National

Center for Chronic Disease Prevention

and Health Promotion, Centers for

Disease Control and Prevention (CDC),

4770 Buford Highway, NE., Mailstop K–

57, Atlanta, GA 30341–3717, telephone

(404) 488–4880 and by fax (404) 488–

4727; by Internet or CDC WONDER

electronic mail at jxm5@cdc.gov or

dxn3@cdc.gov.

Please refer to Program

Announcement Number 98046 when

requesting information and submitting

an application.

Potential applicants may obtain a

copy of ‘‘Healthy People 2000’’ (Full

Report, Stock No. 017–001–00474–0) or

‘‘Healthy People 2000’’ (Summary

Report, Stock No. 017–001–00473–1)

referenced in the Introduction through

the Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325; telephone

(202) 512–1800.

Copies of the U.S. Preventive Services

Task Force Guide to Clinical Preventive

Services, 2nd ed. (Williams & Wilkins,

October 1995) referenced above may be

obtained by calling 1–800–358–3538, or

from the world wide web at http://

www.wwilkins.com/books/data/0–683–

08508–5.html.
26620 Federal Register / Vol. 63, No. 92 /Wednesday, May 13, 1998 / Notices

Data on cancer incidence and

mortality can be obtained from the

following sources:

1. The State Cancer Registry.

2. The American Cancer Society,

Facts and Figures, 1998. 1–800–ACS–

2345.

3. Mortality Statistics Branch,

Division of Vital Statistics, National

Center for Health Statistics, Centers for

Disease Control and Prevention at (301)

436–8884, fax (301) 436–7066. Available

at http://www.cdc.gov/nchswww/

about/major/dvs/mortdata.htm.

4. SEER Cancer Statistics Review,

1973–1994, NIH Pub. No. 97–2789.

Available at http://wwwseer.ims.nci.nih.gov/Publications/

CSR7394/index.html or by calling the

Cancer Statistics Branch Cancer Control

Research Program Division of Cancer

Prevention and Control, National Cancer

Institute at (301) 496–8510.

CDC suggests using the Internet,

following all instructions in this

announcement and leaving messages on

the contact person’s voice mail for more

timely responses to any questions.

Eligibility Assurance Form

All applicants MUST complete this

check-list and attach appropriate

documentation supporting eligibility

(the state/tribe/territory wide

comprehensive cancer control plan).

The plan must be attached to this checklist, should not be incorporated into the

body of the application or the

appendices, and therefore does not

affect the page limit for the application

(30 pages) or appendices (20 pages). A

copy of this form, with an attached

reproducible plan, should be included

with each copy of the application as a

separate tabbed section.

llA state/tribe/territory wide

comprehensive cancer control plan

has been developed. Plan is either:

llan existing up-to-date plan ready

for implementation, or

llan up-to-date detailed final draft

ready for implementation by

September 30, 1998.

At a minimum,

llPlan documents an integrated and

coordinated state/tribe/territory

wide approach to prevention, early

detection, treatment, rehabilitation,

and palliation of cancer (i.e., not a

summation or compilation of

categorical risk factor/specific

cancer programs).

ll Plan identifies priorities to be

addressed based on needs identified

through assessment of the burden of

the major detectable/preventable

cancers in the State/Tribe/Territory.

llCopy of the State/Tribe/Territory

wide comprehensive cancer control

plan document is attached. (A

reproducible, unbound, one-sided,

81⁄2 x 11′′ copy of the plan should

be attached to this form.)

Glossary

Terms are defined by DCPC in this

Glossary to clarify issues for applicants

under this RFA only. They are not

meant to apply to all DCPC or CDC

programs, activities, or RFAs.

Comprehensive Cancer Control: An

integrated and coordinated approach to

reduce the incidence, morbidity, and

mortality [of cancer] through

prevention, early detection, treatment,

rehabilitation, and palliation.

Comprehensive Cancer Control Plan:

Document that is developed as an

optimal blueprint for achieving

comprehensive cancer control in that

State/Tribe/Territory. It should address

information on cancer burden; short-and

long-term goals and objectives;

proposed strategies to meet objectives;

assessment of existing and needed

resources; and a plan for promoting

access to full range of cancer control

services.

At a minimum, a Comprehensive

Cancer Control Plan: (1) documents an

integrated and coordinated state/tribe/

territory wide approach to prevention,

early detection, treatment,

rehabilitation, and palliation of cancer

(i.e., not a summation or compilation of

categorical risk factor/specific cancer

programs); and (2) identifies the

priorities to be addressed based on an

assessment of the burden of the major

detectable/preventable cancers in the

State/Tribe/Territory.

Comprehensive Cancer Control

Program: Based on goals and objectives

established in the comprehensive cancer

control plan, the overall set of actions

that are conducted with available

resources to translate the optimal plan

into feasible reality.

Implementation: Conducting activities

that are designed to achieve goals and

objectives outlined in the

Comprehensive Cancer Control Plan.

Implementing the Plan is the same thing

as conducting comprehensive cancer

control activities or programs. For the

purposes of programs funded under this

RFA, implementation of the plan does

not require that all goals and objectives

in the State/Tribe/Territory wide

comprehensive cancer control plan be

implemented; implementation will be

guided by the goals and objectives in the

implementation plan developed for this

RFA.

Indicator: A performance measure

used to track critical processes over time

to signify progress toward a particular

desired outcome of the program. For

example, one ‘‘indicator’’ for better

coordination among categorical

programs might be a certain number of

meetings held among categorical

program staff to assure that efforts are

being coordinated. Another ‘‘indicator’’

for the same outcome might be that each

related program has a representative on

the coalition that advises and directs the

program.

State/Tribe/Territory wide: Covering

the entire State/Tribe/Territory, rather

than just limited 34 metropolitan or

county areas within the State/Tribe/

Territory. For example, State/Tribe/

Territory wide comprehensive cancer

control plan addresses cancer,

programs, activities, and services

throughout the State/Tribe/Territory.

U.S. Preventive Services Task Force

Guide to Clinical Preventive Services,

2nd ed.: The Guide clearly outlines and

establishes, for the clinician, the current

state of research on the efficacy of the

major preventive interventions. A wellspecified methodology based on

scientific evidence is used to assess

efficacy. Based on the work of a

distinguished panel of nationally

recognized experts, and reviewed by

more than 650 federal and nonfederal

experts, it provides recommendations

on screening, counseling, and

immunizations according to patients’

personal characteristics and health risk

factors.

Dated: May 7, 1998.

Joseph R. Carter,

Acting Associate Director for Management

and Operations, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–12645 Filed 5–12–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Announcement 98037]

Initiatives by Organizations To

Strengthen National Tobacco Control

Activities in the United States; Notice

of Availability of Funds for Fiscal Year

1998; Amendment

A notice announcing the availability

of Fiscal Year 1998 funds for

cooperative agreements for Initiatives by

Organizations to Strengthen National

Tobacco Control Activities in the United

States was published in the Federal

Register on April 23, 1998, [63 FR

20197]. The notice is amended as

follows:

On page 20202, second column, under

the heading ‘‘Application Submission